Skip to main content
. 2016 Jul 18;7(33):53628–53641. doi: 10.18632/oncotarget.10682

Figure 3. Expression of glutamine metabolism-related proteins according to the BRAF V600E mutation status in papillary thyroid cancer.

Figure 3

Papillary thyroid cancer with the BRAF V600E mutation shows higher expression of tumoral GLS1, tumoral GDH, and tumoral ASCT2. GLS1; glutaminase 1, GDH; glutamate dehydrogenase, ASCT2; amino acid transporter-2